| Literature DB >> 33182304 |
Daniele Sadutto1, Yolanda Picó1.
Abstract
Pharmaceuticals and personal care products (PPCPs) are abundantly used by people, and some of them are excreted unaltered or as metabolites through urine, with the sewage being the most important source to their release to the environment. These compounds are in almost all types of water (wastewater, surface water, groundwater, etc.) at concentrations ranging from ng/L to µg/L. The isolation and concentration of the PPCPs from water achieves the appropriate sensitivity. This step is mostly based on solid-phase extraction (SPE) but also includes other approaches (dispersive liquid-liquid microextraction (DLLME), buckypaper, SPE using multicartridges, etc.). In this review article, we aim to discuss the procedures employed to extract PPCPs from any type of water sample prior to their determination via an instrumental analytical technique. Furthermore, we put forward not only the merits of the different methods available but also a number of inconsistencies, divergences, weaknesses and disadvantages of the procedures found in literature, as well as the systems proposed to overcome them and to improve the methodology. Environmental applications of the developed techniques are also discussed. The pressing need for new analytical innovations, emerging trends and future prospects was also considered.Entities:
Keywords: cartridges; concentration; disks; dispersive liquid-liquid microextraction; isolation; online; pharmaceuticals and personal care products; solid-phase extraction; water samples
Mesh:
Substances:
Year: 2020 PMID: 33182304 PMCID: PMC7664861 DOI: 10.3390/molecules25215204
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Selected applications extraction approaches to determine PPCPs in water samples.
| Matrix * | No. of PPCPs | Preservation | Volume (mL) | Extraction Method | Sorbent or Cartridge | Detection | Recovery % | Reference |
|---|---|---|---|---|---|---|---|---|
| WW, SF | 168 | Na4EDTA | 50 | SPE | Clearnert PEP-2 | HPLC-MS/MS | 0.05–127 | [ |
| WW, SF | 168 | Na4EDTA | - | Direct injection | - | HPLC-MS/MS | 0.05–127 | [ |
| SF | 59 | Na2EDTA | 1000 | SPE | Oasis HLB | HPLC-MS/MS | 52–137 | [ |
| WW, SF, DW | 27 | - | - | SPE | Cleanert PEP | HPLC-MS/MS | 74–120 | [ |
| WW | 55 | Na2EDTA | 150 | SPE | Oasis HLB | HPLC-MS/MS | 9–119 | [ |
| SW | 91 | - | 1000 | SPE | Oasis HLB | HPLC-MS/MS | 70–110 | [ |
| WW | 12 | - | 7.9 | DLLME | - | GC-MS/MS | 91–115 | [ |
| WW, SW | 12 | - | 1000 | SPE | Oasis HLB | GC-MS/MS | 65–115 | [ |
| WW, SF, DW | 58 | - | 1.8 | Online-SPE | PLRP-s | HPLC-MS/MS | 70–120 (82% of total) | [ |
| SW | 62 | - | ≤20 | Online-SPE | Oasis HLB | HPLC-MS/MS | 81–120 | [ |
| SW | 62 | - | 200 | SPE | Oasis HLB | HPLC-MS/MS | 81–121 | [ |
| WW, SW | 44 | Na2EDTA | 200 | SPE | Oasis HLB | HPLC-MS/MS | 8–239 | [ |
| SW | 11 | - | 200 | SPE | Strata-X | HPLC-MS/MS | 40–120 | [ |
| SW | 34 | Na2EDTA | 400 | SPE | Oasis HLB | HPLC-MS/MS | 41–125 | [ |
| WW, SW | 30 | Na2EDTA | 250 | SPE | Oasis MCX | HPLC-MS/MS | 78–106 | [ |
| SW | 10 | - | 500 | SPE | Oasis HLB | HPLC-MS/MS | 69–88 | [ |
| WW | 11 | - | - | Online-SPE | TurboFlow™ column | HPLC-MS/MS | 45–150 | [ |
| SW | 16 | - | 10 | DLLME | - | HPLC-MS/MS | 70–120 | [ |
| WW, SW | 27 | Na2EDTA | 125–500 | SPE | Oasis MCX | HPLC-MS/MS | 73–116 | [ |
| WW, SW | 25 (of 41) | Na2EDTA | 120 | PES microextraction | - | HPLC-MS/MS | 80–119 | [ |
| WW, SW | 25 (of 41) | Na2EDTA | 100–250 | SPE | Oasis HLB | HPLC-MS/MS | 71–131 | [ |
| WW, SW | 10 | - | 20 uL | Online-SPE | Oasis HLB | HPLC-MS/MS | - | [ |
| SW | 12 | - | 500 | SPE | Oasis HLB | HPLC-MS/MS | 55–120 | [ |
| WW, SW | 44 | - | 500 | SPE innovative | GCHM, Oasis HLB | HPLC-MS/MS | 76 | [ |
| WW | 190 | - | 100 | SPE innovative | Oasis HLB, Isolute ENV+, | UPLC-Q-TOF-MS/MS | 57–120 | [ |
| Strata-X-AW, Strata-X-CV | ||||||||
| WW | 52 | - | 100 | Disk SPE | BAKERBOND C18 Polar Plus | GC-TOF-MS | - | [ |
| SW | 24 | Na2EDTA | 1000 | SPE | Chromabond HR-X | HPLC-MS/MS | 52–117 | [ |
| SW | 13 | Na2EDTA | 250 | SPE | Strata-X | HPLC-MS/MS | 51–102 | [ |
| SW | 32 | - | 200 | SPE | Strata-X | HPLC-MS/MS | 36–119 | [ |
| SW | 32 | - | 200 | SPE | Strata-X-CW | HPLC-MS/MS | 25–110 | [ |
| SP | 111 | - | 150 | SPE | Strata-X-CW | SFC-MS/MS | 77 (average) | [ |
| WW, SW | 40 | - | 250 | SPE | Oasis HLB | HPLC-MS/MS | 17–146 | [ |
| WW | 11 | - | 250 | SPE | Oasis HLB | HPLC-MS/MS | 53–124 | [ |
| SW | 39 | - | 1000 | SPE | Oasis HLB | HPLC-MS/MS | 1–125 | [ |
| WW | 15 | - | 250 | SPE innovative | Strata-X, PSA, Alumina | GC-MS | 19–103 | [ |
| SW | 69 | - | 100 | SPE | Strata X-CW | SFC-MS/MS | 76 | [ |
| WW, SW | 31 | - | 100–500 | SPE | Chromabond HR-X | HPLC-MS/MS | 32–97 | [ |
| SW | 130 | Na2EDTA | 2000 | SPE innovative | Oasis WAX, Oasis HLB, | HPLC-MS/MS | 50–150 | [ |
| Sep-Pak Plus AC 2 | ||||||||
| WW, DW | 28 | - | 1000 | SPE | C18 Cartridges | HPLC-MS/MS | n.r.–293 | [ |
| WW, SW | 10 | Na2EDTA | 500 | SPE | Oasis HLB | UPLC-Q-TOF-MS/MS | n.r.–128 | [ |
| WW, SW | 23 | - | 500 | SPE | Oasis MCX | HPLC-MS/MS | 54–117 | [ |
| WW | 52 | Na2EDTA | 10 | Online-SPE | Shim-pack MAYI-ODS | HPLC-MS/MS | 74–104 | [ |
| SW | 20 | Na2EDTA | 100 | SPE | Strata-X | HPLC-MS/MS | 70–119 | [ |
| WW, SW | 20 | - | 200 | SPE | Strata-X-Drug B | HPLC-MS/MS | 39–102 | [ |
| SW | 61 | Na2EDTA | 1000 | Disk SPE | Speedisk® | HPLC-MS/MS | - | [ |
| SW | 61 | Na2EDTA | 200 | SPE | Oasis HLB | HPLC-MS/MS | - | [ |
| WW | 26 | Na2EDTA | 500 | SPE | Oasis HLB | HPLC-MS/MS | - | [ |
| WW | 10 | - | - | SPE | Oasis HLB | HPLC-MS/MS | 85–94 | [ |
| SW | 35 | Na2EDTA | 1000 | SPE | Oasis HLB | HPLC-MS/MS | 58–194 | [ |
| WW, SW | 20 | - | 300–400 | SPE | Oasis HLB Prime | GC-MS | ≥40% | [ |
| WW | 83 | Na2EDTA | 50–100 | SPE | Strata-X | HPLC-MS/MS | n.r.–122 | [ |
| WW | 59 | Ascorbic acid; Na2EDTA | 1000 | SPE | Oasis HLB | HPLC-MS/MS | 9–143 | [ |
| WW | 20 | Sodium thiosulfate | 500 | Online-SPE | Oasis HLB | HPLC-MS/MS | - | [ |
| WW | 20 | Sodium thiosulfate | - | Direct injection | - | HPLC-MS/MS | - | [ |
| SW | 13 | - | - | Passive sampling | PES membranes | LC-DAD | - | [ |
| WW | 21 | - | 1000 | SPE | Oasis HLB | LC-HRMS | 40 (average) | [ |
| WW, SW | 103 (of 300) | Formaldehyde | 250 | SPE innovative | Strata-X | UPLC- Q-TOF-MS/MS | - | [ |
| WW | 37 | - | 0.5 | Online-SPE | PLRPs | HPLC-MS/MS | 5–132 | [ |
| WW | 20 | - | 2 | Direct injection | - | HPLC-MS/MS | 60–124 | [ |
| WW | 12 | - | 20–100 | SPE | Oasis HLB | HPLC-MS/MS | 77–115 | [ |
| WW, SW | 48 | - | 300–400 | SPE | Oasis HLB Prime | GC-MS | >40 | [ |
| WW | 38 | - | 100 | SPE | Oasis MCX | HPLC-MS/MS | 65–134 | [ |
| SW | 33 | - | 200 | SPE innovative | Oasis HLB, LC18 column | HPLC-MS/MS | 50–106 | [ |
| SP | 48 | Na4EDTA | 200 | SPE | Oasis MCX | HPLC-MS/MS | 71–122 | [ |
| WW | 22 | NaCl | 100 | Online SPE | DVB/CAR/PDMS | GC-MS | 6–104 | [ |
| WW | 19 | - | 250 | SPE | Oasis HLB | LC-TOF/MS | 5–111 | [ |
| WW | 11 | - | 0.9 | DLLME | - | HPLC-MS/MS | n.r.–124 | [ |
| WW, SW | 40 | - | 1000 | SPE | Oasis HLB | HPLC-MS/MS | n.r.–99 | [ |
| WW, SW | 41 | - | 1000 | SPE | Bond-Elut ENV | HPLC-MS/MS | n.r.–99 | [ |
| SW | 10 (of 28) | - | 500 | Buckypaper Device | - | HPLC-MS/MS | n.r.–102 | [ |
| SW | 44 | - | 200 | SPE | Strata-X | HPLC-MS/MS | 85–100 | [ |
| SW | 45 | Na2EDTA | 1000 | SPE | Strata-X | HPLC-MS/MS | 38–112 | [ |
| WW | 13 | - | 150–300 | SPE | Oasis HLB | HPLC-MS/MS | 40–115 | [ |
| SW | 42 | Na2EDTA; ASA(DW) | 50 | SPE | Oasis HLB | HPLC-MS/MS | 33–117 | [ |
| WW, SW | 39 (of 80) | - | 500–100 | SPE | Oasis MCX; Oasis HLB | HPLC-MS/MS | 31–131 | [ |
| SW | 110 | Phosphate buffer | 1000 | Disk SPE | Glass microfiber, | GC-TOF-MS/MS | - | [ |
| Empore™ SDB-XD, Empore™ AC | ||||||||
| WW | 82 | - | 250 | SPE | Oasis HLB | LC–Q-TOF-MS | 66–149 | [ |
| SW | 35 | - | 100–500 | SPE | Oasis HLB | HPLC-MS/MS | 2–132 | [ |
| WW, SW | 10 | - | 50–100 | SPE innovative | Oasis MCX, Oasis MAX | LC-HRMS | 60–109 | [ |
| WW, SW | 10 | Sodium azide; | 200–1000 | Disk SPE | Atlantic HLB | HPLC-MS/MS | 48–122 | [ |
| ascorbic acid | ||||||||
| WW, SW | 10 | Sodium azide | 200-1000 | SPE | Oasis HLB | HPLC-MS/MS | 1–110 | [ |
| ascorbic acid | ||||||||
| WW | 17 | - | 250 | SPE | Oasis HLB | HPLC-MS/MS | <40% | [ |
| SW | 10 | Citric acid | 1000 | SPE | C18 | HPLC-MS/MS | 97–101 | [ |
| WW | 100 | - | 200 | SPE | UCT XRDAH | LC-Q-TOF-MS/MS | - | [ |
* WW = Wastewater; SF = Surface water; SP = Swimming pool water. n.r. = not recovered.
Figure 1Pharmaceuticals and personal care products (PPCPs) extraction procedures according to the percentage of studies that applied them. SPE: solid-phase extraction.
Mechanism, type of sorbent and target of the most used brand name of offline columns.
| Brand Name | Mechanism | Sorbent | Target |
|---|---|---|---|
| Oasis HLB, HLB Prime | RP | divinylbenzene-co- | acidic, basic, and neutral compounds |
| STRATA-X | RP | styrene-divinylbenzene-co- | acidic, basic, and neutral compounds |
| Cleanert PEP | RP | divinylbenzene-co- | acidic, basic, and neutral compounds |
| Isolute ENV+ | RP | polystyrene-divinylbenzene (PS-DVB) | polar compounds |
| Bond-Elut ENV | RP | polystyrene-divinylbenzene (PS-DVB) | polar compounds |
| Chromabond HR-X | RP | polystyrene-divinylbenzene (PS-DVB) | polar compounds |
| Oasis MCX | IC | mixed-mode CATION-exchange polymer-based | basic compounds, particularly strong bases |
| Oasis WAX | IC | mixed-mode ANION-exchange sorbent polymer-based | acidic compounds |
| Strata-X-CW | IC | mixed-mode CATION-exchange polymer-based | basic compounds, particularly strong bases |
| Strata-X-AW | IC | mixed-mode ANION-exchange sorbent Polymer-based | acidic compounds |
| Strata-X-Drug B | IC | mixed-mode strong CATION-exchange polymer-based | basic compounds, particularly strong bases |
| UCT XRDAH | IC | mixed-mode CATION-exchange polymer-based | basic compounds, particularly strong bases |
Figure 2Percentage of studies according to water volume.
Figure 3Percentage of studies according to the type of eluent used.
Figure 4Configuration of the online SPE liquid chromatography tandem mass spectrometry (SPE-LC-MS/MS) system. I. separation column equilibration (pump A and B); II. sample loading and trapping (pump C); III. SPE desorption (pump A and B) and cleaning (pump D). Reproduced from [68] with permission from Elsevier. (a) Sample loading (Pump A, B, and C: On); (b) Sample analysis (Pump A, B, and D: On).
Figure 5Percentage of studies according to the number of PPCPs analyzed.